
TY  - JOUR
AU  - Isbir, Turgay
TI  - Abstracts: Turkish Society of Molecular Medicine, Third International Congress of Molecular Medicine, May 5–8, 2009, Istanbul, Turkey
JO  - IUBMB Life
JA  - IUBMB Life
VL  - 61
IS  - 3
SN  - 1521-6543
UR  - https://doi.org/10.1002/iub.183
DO  - doi:10.1002/iub.183
SP  - 273
EP  - 389
PY  - 2009
ER  - 

TY  - JOUR
TI  - Neurotrauma and Injury, Pain, Regeneration and Repair
JO  - Journal of Neurochemistry
VL  - 87
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1046/j.1474-1644.2003.2175_14.x
DO  - doi:10.1046/j.1474-1644.2003.2175_14.x
SP  - 144
EP  - 151
PY  - 2003
ER  - 

TY  - JOUR
TI  - Annual Dialysis Conference February 8-11, 2020 Kansas City, Missouri
JO  - Hemodialysis International
JA  - Hemodialysis International
VL  - 24
IS  - 1
SN  - 1492-7535
UR  - https://doi.org/10.1111/hdi.12814
DO  - doi:10.1111/hdi.12814
SP  - A1
EP  - A20
PY  - 2020
ER  - 

AU  - Lee, Harry
C7  - pp. 41-64
TI  - Causation
SN  - 9780470512296
UR  - https://doi.org/10.1002/9780470512364.ch3
DO  - doi:10.1002/9780470512364.ch3
SP  - 41-64
KW  - Gulf War syndrome causes
KW  - leishmaniasis in Gulf veterans
KW  - vaccination and veteran long term ill health
KW  - Gulf War/era veterans – Seabee health study
KW  - organophosphates (Ops) and Organophosphate Pesticide Investigation Team (OPPIT)
PY  - 2020
AB  - Summary This chapter contains sections titled: Introduction Possible Causes of Gulf War Syndrome References
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 273
IS  - s1
SN  - 9780470512296
UR  - https://doi.org/10.1111/j.1742-4658.2006.05277.x
DO  - doi:10.1111/j.1742-4658.2006.05277.x
SP  - 77
EP  - 367
PY  - 2006
ER  - 

TY  - JOUR
TI  - Subspecialty Poster Sessions
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 45
IS  - s2
SN  - 9780470512296
UR  - https://doi.org/10.1111/eci.12436
DO  - doi:10.1111/eci.12436
SP  - 69
EP  - 92
PY  - 2015
ER  - 

C7  - pp. 99-120
TI  - Inflammation-Related Factors
SN  - 9781118829912
UR  - https://doi.org/10.1002/9781118829875.ch5
DO  - doi:10.1002/9781118829875.ch5
SP  - 99-120
KW  - antioxidants
KW  - cardiovascular disease
KW  - chronic inflammatory disease
KW  - dietary patterns
KW  - erythrocyte sedimentation rate
KW  - high-sensitivity-C-reactive protein
KW  - inflammation markers
KW  - Lp-PLA2
KW  - pharmacological agents
PY  - 2015
AB  - Summary This chapter reviews current knowledge of the role of inflammation in cardiovascular disease (CVD) and describes emerging markers of inflammation in CVD. It examines whether individuals identified on the basis of elevated serum high-sensitivity (hs)-C-reactive protein (CRP) benefit from clinical intervention. The chapter reviews existing guidelines relating to hs-CRP and highlights limitations in the use of hs-CRP in risk assessment. It evaluates the prognostic value of other inflammatory markers, including fibrinogen, cytokines, chemokines, adhesion molecules, serum amyloid A, albumin, leukocyte count, erythrocyte sedimentation rate, circulating immune complexes, heat-shock proteins, matrix metalloproteinases, lipoprotein-associated phospholipase A2 (Lp-PLA2), paraoxonase-1, and myeloperoxidase in CVD. The chapter reviews the influence of chronic inflammatory disease and infectious burden on CVD, and discusses relevant data regarding pharmacological agents with anti-inflammatory effects in CVD. It evaluates the influence of dietary patterns, wholegrains, dietary fat, antioxidants, phytochemicals, plant sterols, alcohol, micronutrients, physical activity, genetics, and family history on inflammatory markers associated with CVD.
ER  - 

TY  - JOUR
TI  - ABSTRACTS—POSTERS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 33
IS  - s1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1530-0277.2009.00957.x
DO  - doi:10.1111/j.1530-0277.2009.00957.x
SP  - 11A
EP  - 265A
PY  - 2009
ER  - 

TY  - JOUR
AU  - Cacabelos, Ramón
TI  - Pharmacogenomics of Central Nervous System (CNS) Drugs
JO  - Drug Development Research
JA  - Drug Dev. Res.
VL  - 73
IS  - 8
SN  - 9781118829912
UR  - https://doi.org/10.1002/ddr.21039
DO  - doi:10.1002/ddr.21039
SP  - 461
EP  - 476
KW  - CNS disorders
KW  - Alzheimer's disease
KW  - pharmacogenomics
KW  - CYP2D6
KW  - CYP2C9
KW  - CYP2C19
KW  - CYP3A4/5
KW  - APOE
KW  - transporters
KW  - psychotropic drugs
PY  - 2012
AB  - Abstract Preclinical Research Central nervous system (CNS) disorders represent a major problem of health in developed countries, with important consequences in disability and health economics. Recent findings in CNS genomics and pharmacogenomics suggest that the introduction of pharmacogenomic procedures in clinical practice may help to optimize therapeutics (efficacy and safety issues). The genes involved in the pharmacogenomics of CNS drugs fall into five categories: (i) genes associated with CNS pathogenesis; (ii) genes associated with the mechanism of action of drugs; (iii) genes associated with drug metabolism; (iv) genes associated with drug transporters; and (v) pleiotropic genes involved in multifaceted cascades and metabolic reactions. Pharmacogenomics accounts for 30?90% variability in pharmacokinetics and pharmacodynamics. Only 20?30% of the Caucasian population processes normally approximately 60% of the current drugs that are metabolized via CYP2D6, CYP2C9, and CYP2C19. Clinical pharmacogenomics may contribute to personalizing pharmacological treatment, predicting patient/drug-dose selection, minimizing drug interactions, increasing drug efficacy, and reducing unnecessary costs.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 98
IS  - S5
SN  - 9781118829912
UR  - https://doi.org/10.1002/bjs.7578
DO  - doi:10.1002/bjs.7578
SP  - 50
EP  - 69
PY  - 2011
AB  - Abstract The 46th Congress of the European Society for Surgical Research takes place this year in Aachen, Germany, 25?28 May. Copyright ? 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 9 September
JO  - European Journal of Neurology
VL  - 19
IS  - s1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1468-1331.2012.03888.x
DO  - doi:10.1111/j.1468-1331.2012.03888.x
SP  - 90
EP  - 457
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Session 1: Abstracts
JO  - International Journal of Stroke
VL  - 1
IS  - s1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1747-4949.2006.00072.x
DO  - doi:10.1111/j.1747-4949.2006.00072.x
SP  - 49
EP  - 108
PY  - 2006
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Respirology
VL  - 13
IS  - s5
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1440-1843.2008.01426.x
DO  - doi:10.1111/j.1440-1843.2008.01426.x
SP  - A101
EP  - A138
PY  - 2008
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Diabetic Medicine
VL  - 23
IS  - s2
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1466-5468.2006.01875.x
DO  - doi:10.1111/j.1466-5468.2006.01875.x
SP  - 31
EP  - 138
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 13 September
JO  - European Journal of Neurology
VL  - 16
IS  - s3
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1468-1331.2009.02821.x
DO  - doi:10.1111/j.1468-1331.2009.02821.x
SP  - 55
EP  - 334
PY  - 2009
ER  - 

TY  - JOUR
TI  - Main Symposia And Workshops
JO  - The FEBS Journal
JA  - FEBS J
VL  - 280
IS  - s1
SN  - 9781118829912
UR  - https://doi.org/10.1111/febs.12340
DO  - doi:10.1111/febs.12340
SP  - 3
EP  - 617
PY  - 2013
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 9781118829912
UR  - https://doi.org/10.1002/jbmr.5650221407
DO  - doi:10.1002/jbmr.5650221407
SP  - s252
EP  - s301
PY  - 2007
ER  - 

TY  - JOUR
TI  - 2016 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 68
IS  - S10
SN  - 9781118829912
UR  - https://doi.org/10.1002/art.39977
DO  - doi:10.1002/art.39977
SP  - 1
EP  - 4550
PY  - 2016
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1432-2277.2011.01351.x
DO  - doi:10.1111/j.1432-2277.2011.01351.x
SP  - 230
EP  - 321
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1538-7836.2005.03000.x
DO  - doi:10.1111/j.1538-7836.2005.03000.x
SP  - H01
EP  - SYM90
PY  - 2005
ER  - 
